Skip to content
Calculator
Guide

Endotoxins, heavy metals and TFA: what a COA rarely shows

Last updated: October 27, 2026 · 9 min read · By the Grey Peptides Editorial Board

Close-up of a laboratory test tube rack with colorful chemical solutions, emphasizing scientific research
Photo by https://kaboompics.com/ on Pexels
Grey Peptides
Grey Peptides Editorial Board
Every status on this page carries the date it was checked. How we work
Key takeaways
  • HPLC purity answers one question: how much of the material is the right peptide rather than closely related peptides. It does not measure bacterial endotoxin, sterility, heavy metals, solvents or the salt the peptide is supplied as.
  • Each of those has an official standard for injectable drugs: an endotoxin ceiling of 5 EU per kg of body weight, sterility testing, and daily limits for lead, cadmium, arsenic and mercury. A research-use-only label says nothing about whether a vial meets any of them.
  • When researchers bought semaglutide vials from illegal online pharmacies, endotoxin was measured at 8.95 EU/mg in one vial, and semaglutide made up only 7.7% to 14.4% of the powder against sellers' claims of at least 99% purity.

What '99% purity' does and does not mean

The number on most peptide certificates of analysis is HPLC purity: the share of the material that elutes as the target peptide rather than as related peptides, such as truncated or modified sequences. It is a useful number, and it answers a narrow question. It says nothing about whether the vial contains bacterial toxins, live microorganisms, toxic metals, leftover solvents from synthesis, or what salt the peptide is bound to. A peptide can be 99% pure by HPLC and still be unsafe to inject.

For drugs, US manufacturing rules require that each batch of a product purporting to be sterile or pyrogen-free be tested in the laboratory for conformance, under written procedures 1. A research-chemical label makes no such claim. A 2018 review of falsified peptide and protein drugs by a Belgian national medicines laboratory lists the problems found in seized products: the wrong active ingredient, the wrong dose or none at all, toxic contaminants, and impurities from the product or its manufacture 2. The rest of this guide takes those hidden contaminants one at a time.

Endotoxin: the bacterial toxin filters do not remove

Endotoxin is lipopolysaccharide from the outer membrane of gram-negative bacteria, released when the bacteria die and break apart. FDA's inspection guide notes that it is not removed by sterilising or microbiological filters, and that fever is its most emphasised effect; injectable drugs are tested for it with the bacterial endotoxins test, also called the Limulus amebocyte lysate (LAL) test 3.

The ceiling is set by body weight, not by the vial. USP chapter 85 recommends a maximum endotoxin exposure of no more than 5 endotoxin units (EU) per kilogram of body weight for most drugs, 0.2 EU/kg for drugs given into the spinal fluid, and 100 EU per square metre for products dosed by body surface area 4. Product limits are calculated from that threshold with the formula K/M, where K is 5 EU/kg and M is the maximum dose per kilogram 5. Even the water matters: FDA's inspection guide gives a limit of 0.25 EU/mL for Water for Injection and 0.5 EU/mL for Bacteriostatic Water for Injection 3.

What turns up in practice? Researchers in Hungary bought semaglutide from illegal online pharmacies in 2023. Of six orders, the three for vials arrived; none of the three prefilled pens ordered ever did. All three vials failed most of a packaging inspection, and although no live microorganisms grew, endotoxin was measured at 8.95 EU per mg in one vial; the other two were reported only as below 2.9 and 2.2 EU per mg 6. Whether that crosses the threshold depends on the dose injected and the person's weight, which is exactly why a certificate needs to report endotoxin per milligram, measured on that batch.

A worked example: why the limit is per kilogram

The per-kilogram ceiling makes the arithmetic personal, and it is worth doing honestly. FDA describes the 5 EU/kg figure as an exposure within one hour, based on an average patient weight of 70 kg 4, and its draft guidance calls K the threshold pyrogenic dose 5, so a 70 kg adult's threshold is about 350 EU per injection. Take the one semaglutide vial in the Hungarian study with a measured level, 8.95 EU per mg 6. A 1 mg injection from it would deliver about 9 EU, roughly 0.13 EU per kg, and even a 2.4 mg dose would deliver about 21 EU, around 0.3 EU per kg. On those numbers, the endotoxin found would not have crossed the fever threshold at semaglutide's small doses.

That is not reassurance; it is the reason a certificate must report the figure. The same contamination per milligram becomes a problem as doses rise, as body weight falls, or when several products and a contaminated diluent are injected together, and nothing about one batch tells you the next. The study's more alarming findings were the others: semaglutide making up only 7.7% to 14.4% of the powder against sellers' claims of at least 99% purity, packaging that failed most quality criteria, and half of the orders never arriving at all 6.

Sterility: a separate test from endotoxin

Sterility and endotoxin are often confused. A sterility test asks whether anything in the sample can still grow; an endotoxin test asks whether bacterial toxin is present, alive or dead. A vial can pass one and fail the other, as one of the semaglutide samples did: no viable microorganisms, yet endotoxin measured at 8.95 EU per mg 6. A powder that was sterile on the day it was tested can also be contaminated later: CDC warns that a needle left in a vial's septum creates a direct route for microorganisms to enter the vial, and that vials can become a source of infection when used inappropriately or contaminated 7.

For drug products purporting to be sterile, each batch must be tested for conformance 1. A research vial's label promises no such testing, and a certificate that lists only identity and HPLC purity has not tested for sterility.

Heavy metals and other elemental impurities

Metals reach drugs through catalysts, equipment, reagents and water. Regulators handle them through a risk-based framework, adopted in FDA guidance as ICH Q3D, which sets a permitted daily exposure for each element and route 8. For injectable products, USP chapter 232 lists daily limits of 2 micrograms for cadmium, 5 for lead, 15 for inorganic arsenic and 3 for inorganic mercury, lower than the oral limits for cadmium and mercury 9.

A certificate from an accredited laboratory can report an elemental impurity screen; one that does not list it has not tested for it.

TFA: the salt hiding in most synthetic peptides

Almost every synthetic peptide passes through trifluoroacetic acid (TFA). It is used to cut the finished peptide from the resin it was built on and as an ion-pairing reagent in HPLC purification, so peptides usually come out as TFA salts 10. That has two consequences that a purity figure hides.

The first is mass. A vial labelled as a given number of milligrams of a TFA salt contains less peptide than that, because part of the weight is counter-ion; how much depends on the sequence, because positively charged amino acids hold more TFA 10. The second is biology. In a 1999 study, TFA at concentrations as low as 10-8 to 10-7 M reduced the growth of bone-forming cells and cartilage cells in culture, and the TFA salts of three peptides consistently produced less cell proliferation than their hydrochloride salts, enough to hide a real effect or create a false one. The authors recommended converting peptides to the hydrochloride form before testing them 11. A 2025 study validated methods for measuring residual TFA and for exchanging it for chloride, and found the salt form changed how readily some peptides crossed a model membrane 10.

The 2025 authors concluded that counter-ion quantification and specification matter 10. A research vial that does not state its counter-ion, or a certificate that does not report TFA content, leaves both the dose and the chemistry uncertain.

Residual solvents and process impurities

The 2018 review of falsified peptide drugs lists product- and process-related impurities among their hazards 2. What a test finds depends on what it can see: in two short custom peptides bought commercially for research, nuclear magnetic resonance found that 20% and 43% of the material by weight was mannitol, a UV-transparent sugar alcohol nobody had declared, which the usual UV-based chromatography can miss 12.

Contamination matters in research too. A 2025 laboratory study found that the immune-receptor activation attributed to cereal amylase trypsin inhibitors was dominated by bacterial lipopolysaccharide, another name for endotoxin, in the preparation: blocking the endotoxin cut the signal by 92% 13. If endotoxin can fool a laboratory into crediting a protein with an effect, it can fool a person injecting a gray-market peptide into crediting the peptide with the fever or the inflammation.

What testing of real products finds

Analyses of products from outside the regulated supply keep finding the same problems. A French toxicology laboratory analysed 110 products seized from bodybuilders between 2016 and 2019: of 75 pharmaceuticals, 33% were substandard in dose, 32% counterfeit in content, and only 19% matched their label 14. In the semaglutide test purchases, the vials held 28.6% to 38.7% more semaglutide than labelled, yet semaglutide made up only 7.7% to 14.4% of the powder, against sellers' claims of at least 99% purity 6. A falsified product can be over-strength, mostly something else and contaminated at the same time.

What a complete certificate should report

Our COA decoder reads a certificate and flags what is missing. In plain terms, a certificate that supports an injectable product should name the laboratory and its accreditation, the lot number and test date, and then at least: identity by mass spectrometry, HPLC purity with the chromatogram, net peptide content and counter-ion, bacterial endotoxin in EU per mg, sterility, and, ideally, residual solvents and elemental impurities. A certificate that stops after the first two has tested none of the rest.

Even a complete certificate describes only the sample the laboratory received, which may not be the vial you hold. That is the gap our guide to evaluating a peptide source and our page on what research use only means try to explain, and it is why approved products, made and batch-tested under drug manufacturing rules 1, are the ones whose contents are held to a standard.

Frequently asked questions

Does 99% purity mean a peptide is safe?

No. HPLC purity measures how much of the material is the target peptide rather than related peptides. It does not test for bacterial endotoxin, sterility, heavy metals, residual solvents or the TFA salt.

What is the endotoxin limit for injectable drugs?

USP chapter 85 recommends a maximum endotoxin exposure of 5 EU per kg of body weight for most drugs and 0.2 EU per kg for drugs given into the spinal fluid; product limits are calculated from that with the K/M formula.

What is TFA in peptides?

Trifluoroacetic acid, used in peptide synthesis and HPLC purification, which leaves synthetic peptides as TFA salts unless the counter-ion is exchanged. It adds weight that is not peptide and has affected cells in laboratory studies at low concentrations.

Is a small amount of endotoxin dangerous?

It depends on dose and body weight. The ceiling is 5 EU per kg within an hour, so the same contamination per milligram matters more as the dose rises or body weight falls. Without a measured figure on the certificate, there is no way to know.

Have gray-market peptides been tested for endotoxin?

Yes. In a 2024 study of semaglutide vials bought from illegal online pharmacies, endotoxin was measured at 8.95 EU per mg in one vial and reported only as below 2.9 and 2.2 EU per mg in the other two; semaglutide made up only 7.7% to 14.4% of the powder.

Sources

  1. 21 CFR 211.167(a), Special testing requirements: 'For each batch of drug product purporting to be sterile and/or pyrogen-free, there shall be appropriate laboratory testing to determine conformance to such requirements.' eCFR, read October 27, 2026. eCFR
  2. Janvier, S., et al. (2018). Falsification of biotechnology drugs: current dangers and/or future disasters? J Pharm Biomed Anal, 161, 175-191. PMID: 30165334
  3. FDA. Inspection Technical Guide: Bacterial Endotoxins/Pyrogens (endotoxin not removed by sterilising filters; LAL test; Water for Injection 0.25 EU/mL; Bacteriostatic Water for Injection 0.5 EU/mL). Content current as of November 17, 2014; re-read October 27, 2026. FDA
  4. FDA. Questions and Answers on Quality-Related Controlled Correspondence: Microbiology (Endotoxin testing: USP <85> 5 EU/kg within 1 hour, average patient weight 70 kg). Content current as of November 21, 2025; re-read October 27, 2026. FDA
  5. FDA. Draft guidance: setting endotoxin limits during development of investigational oncology drugs and biological products (draft, July 2020; K/M formula; K = 5 EU/kg, the threshold pyrogenic dose). Re-read October 27, 2026. FDA
  6. Ashraf, A. R., et al. (2024). Multifactor Quality and Safety Analysis of Semaglutide Products Sold by Online Sellers Without a Prescription: Market Surveillance, Content Analysis, and Product Purchase Evaluation Study. J Med Internet Res, 26, e65440. PMID: 39509151
  7. Centers for Disease Control and Prevention. Preventing Unsafe Injection Practices (Injection Safety: clinical safety; last reviewed March 26, 2024). Read October 27, 2026. CDC
  8. FDA. Q3D(R2) Elemental Impurities: Guidance for Industry. Read October 3, 2026. FDA
  9. United States Pharmacopeia. General Chapter <232> Elemental Impurities: Limits, Table 1 (parenteral daily-dose PDEs: cadmium 2, lead 5, inorganic arsenic 15, inorganic mercury 3 micrograms per day). Text published by USP; read October 3, 2026.
  10. Erckes, V., et al. (2025). Towards a Consensus for the Analysis and Exchange of TFA as a Counterion in Synthetic Peptides and Its Influence on Membrane Permeation. Pharmaceuticals (Basel), 18(8). PMID: 40872554
  11. Cornish, J., et al. (1999). Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. Am J Physiol, 277(5), E779-83. PMID: 10567002
  12. Choules, M. P., et al. (2020). NMR reveals an undeclared constituent in custom synthetic peptides. J Pharm Biomed Anal, 178, 112915. PMID: 31671336
  13. Krouch, D., et al. (2025). Amylase trypsin inhibitors activation of toll-like receptor 4 revisited: The dominance of lipopolysaccharides contamination. Int J Biol Macromol, 310(Pt 4), 143378. PMID: 40288707
  14. Fabresse, N., et al. (2021). Analysis of pharmaceutical products and dietary supplements seized from the black market among bodybuilders. Forensic Sci Int, 322, 110771. PMID: 33838562

Educational information, not medical advice. Each dose in this guide names its source, an approved label or a published study. None is a recommendation for you. An unapproved compound has no established safe or effective human dose, and products sold for “research use only” are not made or tested for people. Talk to a doctor before acting on anything on this site, including before you start, stop or change any medicine or dose.

All articles

New guides and rule changes, by email

One short email when a peptide's legal status moves — an FDA or PCAC decision, a WADA list change, an enforcement action — plus new guides and tools. At most one a week, and none when nothing changes. The newsletter has not started sending yet: your first email will be its first issue.

We keep your email address and the page you signed up from, nothing else. How it works · Privacy · RSS instead